MAHLY (Medipal Holdings) NonCurrent Deferred Liabilities: $0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MAHLY Medipal Holdings Corp MAHLY
74 GF Score
Price $18.30
GF Value $16.39
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Medipal Holdings NonCurrent Deferred Liabilities?

Medipal Holdings MAHLY +3.80% 74 NonCurrent Deferred Liabilities is $0 Mil as of Mar. 2026. GuruFocus rates MAHLY with a GF Score™ of 74/100 and a GF Value™ of $16.39 (Modestly Overvalued). The stock has 6 warning signs investors should review.

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Medipal Holdings's non-current deferred liabilities for the quarter that ended in Mar. 2026 was $0 Mil.

Medipal Holdings NonCurrent Deferred Liabilities Related Terms

Medipal Holdings NonCurrent Deferred Liabilities Historical Data

* Premium members only.

The historical data trend for Medipal Holdings's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medipal Holdings NonCurrent Deferred Liabilities Chart

Medipal Holdings Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Medipal Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
MAHLY
74GF Score
Medipal Holdings Corp MAHLY
NonCurrent Deferred Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a NonCurrent Deferred Liabilities of $0 Mil mean?
Medipal Holdings (MAHLY) has a NonCurrent Deferred Liabilities of $0 Mil as of Mar. 2026. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Medipal Holdings and its competitors.
Is Medipal Holdings' NonCurrent Deferred Liabilities too high?
Medipal Holdings' current NonCurrent Deferred Liabilities is $0 Mil. Overall, Medipal Holdings has a GF Score™ of 74/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medipal Holdings' NonCurrent Deferred Liabilities compare to MCK and COR?
Medipal Holdings' NonCurrent Deferred Liabilities of $0 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Liabilities for a Medical Distribution company?
A good NonCurrent Deferred Liabilities depends on the Medical Distribution industry context. However, NonCurrent Deferred Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Liabilities mean?
A high NonCurrent Deferred Liabilities can signal that a stock is expensive relative to its fundamentals. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Medipal Holdings and its competitors. Medipal Holdings's current NonCurrent Deferred Liabilities is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medipal Holdings stock overvalued right now?
Based on GuruFocus' analysis, Medipal Holdings (MAHLY) is currently considered Modestly Overvalued. The stock's GF Value™ is $16.39, compared to a current price of $18.30 — trading 11.7% above its estimated fair value. The current NonCurrent Deferred Liabilities is $0 Mil. Medipal Holdings' overall GF Score™ is 74/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Liabilities calculated?
NonCurrent Deferred Liabilities is calculated from a company's financial statements. For Medipal Holdings (MAHLY), the current NonCurrent Deferred Liabilities is $0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medipal Holdings (MAHLY) Overvalued in 2026?

Based on GuruFocus' analysis, Medipal Holdings stock appears to be overvalued. The current stock price of $18.30 is trading 11.7% above its estimated GF Value™ of $16.39. GuruFocus considers Medipal Holdings to be Modestly Overvalued.

Key valuation signals for MAHLY:

  • NonCurrent Deferred Liabilities: $0 Mil
  • GF Value™: $16.39 vs. price of $18.30 (11.7% above fair value)
  • GF Score™: 74/100 with 6 warning signs

No single metric tells the full story. See the MAHLY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medipal Holdings Business Description

Other Exchanges MEPDF:USA7459:Japan
Address 3-1-1 Kyobashi, Chuo-ku, Tokyo, JPN, 104-8461
Medipal Holdings Corp is engaged in the wholesale distribution of pharmaceuticals, cosmetics, daily necessities, and related products. The company operates through three reportable segments: Wholesale business of medical drugs; Cosmetics, Daily Necessities and OTC Pharmaceuticals Wholesale Business; and Wholesale of animal medicines and food processing ingredients. The Wholesale business of medical drugs segment targets hospitals, clinics, and dispensing pharmacies; the Cosmetics and OTC segment serves drug stores, home centers, convenience stores, and supermarkets; while the Wholesale of animal medicines and food processing ingredients segment supplies veterinary clinics, livestock and fisheries businesses, and food manufacturers.
74GF Score

Get the complete analysis for MAHLY

NonCurrent Deferred Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$18.30
Price
$16.39
GF Value